Table 1. Clinicopathological correlation analysis between SALL4 expression and patients.
Clinical features | SALL4 expression | P | |
---|---|---|---|
Low expression (n=20) | High expression (n=42) | ||
Gender | 0.239 | ||
Male | 11 | 25 | |
Female | 9 | 17 | |
Age | 0.946 | ||
<50 | 7 | 15 | |
≥50 | 13 | 27 | |
Differentiation | 0.137 | ||
Poorly differentiated | 15 | 29 | |
Well differentiated | 5 | 13 | |
Smoking | 0.322 | ||
Yes | 8 | 17 | |
No | 12 | 25 | |
Tumor size | 0.418 | ||
≤3 cm | 7 | 19 | |
>3 cm | 13 | 23 | |
TNM staging | 0.012* | ||
I–II | 15 | 20 | |
III–IV | 5 | 22 | |
Lymph node | 0.002* | ||
Metastasis | 14 | 19 | |
No | 6 | 23 |
*, P<0.05. SALL4, Sal-like protein 4.